Los Angeles Capital Management LLC Buys 18,797 Shares of Owens & Minor, Inc. $OMI

Los Angeles Capital Management LLC boosted its stake in shares of Owens & Minor, Inc. (NYSE:OMI) by 19.9% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 113,162 shares of the company’s stock after buying an additional 18,797 shares during the period. Los Angeles Capital Management LLC owned approximately 0.15% of Owens & Minor worth $1,030,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. DekaBank Deutsche Girozentrale grew its stake in shares of Owens & Minor by 76.6% in the second quarter. DekaBank Deutsche Girozentrale now owns 3,126 shares of the company’s stock worth $28,000 after acquiring an additional 1,356 shares during the last quarter. Quarry LP purchased a new position in shares of Owens & Minor in the 1st quarter worth about $34,000. Headlands Technologies LLC bought a new position in Owens & Minor in the 1st quarter worth about $55,000. Blue Trust Inc. boosted its stake in Owens & Minor by 52.2% in the 2nd quarter. Blue Trust Inc. now owns 6,709 shares of the company’s stock worth $61,000 after purchasing an additional 2,302 shares in the last quarter. Finally, Public Employees Retirement System of Ohio grew its position in Owens & Minor by 25.0% during the 2nd quarter. Public Employees Retirement System of Ohio now owns 9,660 shares of the company’s stock valued at $88,000 after purchasing an additional 1,932 shares during the last quarter. Hedge funds and other institutional investors own 98.04% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on OMI. Zacks Research cut shares of Owens & Minor from a “hold” rating to a “strong sell” rating in a report on Monday. Baird R W raised shares of Owens & Minor from a “hold” rating to a “strong-buy” rating in a research report on Friday, August 8th. Citigroup reaffirmed a “buy” rating and issued a $7.00 price objective (down from $11.00) on shares of Owens & Minor in a research report on Tuesday, August 12th. Bank of America reduced their target price on Owens & Minor from $7.50 to $4.75 and set an “underperform” rating for the company in a report on Tuesday, August 12th. Finally, Robert W. Baird decreased their price target on Owens & Minor from $10.00 to $7.00 and set an “outperform” rating for the company in a research note on Tuesday, August 12th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and four have given a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $6.35.

Owens & Minor Trading Up 3.3%

NYSE:OMI opened at $2.94 on Thursday. The company has a market cap of $227.63 million, a PE ratio of -0.19 and a beta of 1.27. The company has a current ratio of 0.86, a quick ratio of 0.83 and a debt-to-equity ratio of 3.32. The company has a 50 day simple moving average of $4.74 and a two-hundred day simple moving average of $6.27. Owens & Minor, Inc. has a 12 month low of $2.85 and a 12 month high of $15.54.

Owens & Minor (NYSE:OMI) last released its quarterly earnings results on Thursday, October 30th. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.02. Owens & Minor had a positive return on equity of 26.59% and a negative net margin of 13.78%.The firm had revenue of $697.26 million for the quarter, compared to analysts’ expectations of $704.06 million. During the same period in the prior year, the firm earned $0.36 EPS. The company’s revenue was up 1.5% compared to the same quarter last year. Owens & Minor has set its FY 2025 guidance at 1.020-1.070 EPS. Research analysts forecast that Owens & Minor, Inc. will post 1.51 earnings per share for the current year.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.